Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Is myoblast transplantation effective?

Nature Medicine volume 4, pages 1208–1209 (1998)Cite this article

To the editor— Nature Medicine has emphasized the controversial program of myoblast transplantation into Duchenne muscular dystrophy (DMD) patients undertaken by the Cell Therapy Research Foundation (CTRF) in Memphis1,2. We have previously suggested3 that the confrontational aspects of this work are unnecessary and easily resolved by simple investigation. In particular, we have argued that it can be misleading to use immunostaining with a single polyclonal antibody to demonstrate donor dystrophin4,5. This is because many biopsies of DMD muscle contain variable numbers of so called 'revertant' fibers that contain immunochemically demonstrable dystrophin6. The mechanism underlying this expression of 'revertant' dystrophin is unknown, but, where the patient has an identified genomic deletion from his dystrophin gene, it is possible to show that the 'revertant' dystrophin lacks exons encoded by the deleted region7,8. We now report findings on biopsy samples volunteered by the family of one of the subjects of the CTRF program.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Birmingham, K. Controversial muscular dystrophy therapy goes to court. Nature Med. 3, 1058 (1997).

    CAS  Article  Google Scholar 

  2. Birmingham, K. FDA reprimands muscular dystrophy clinic. Nature Med. 4, 10 (1998).

    Article  Google Scholar 

  3. Partridge, T.A. et al. Meeting of the Cell Transplantation Society in Miami [letter; comment]. Cell Transplant. 6, 195 –198 (1997).

    CAS  PubMed  Google Scholar 

  4. Law, P.K. et al. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy [letter]. Lancet 336, 114–115 (1990).

    CAS  Article  Google Scholar 

  5. Law, P.K. et al. Human gene therapy with myoblast transfer. Transplant. Proc. 29, 2234–2237 ( 1997).

    CAS  Article  Google Scholar 

  6. Nicholson, L.V., Johnson, M.A., Bushby, K.M. & Gardner Medwin, D. Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy. Arch. Dis. Child. 68, 632– 636 (1993).

    CAS  Article  Google Scholar 

  7. Mendell, J.R. et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333, 832– 838 (1995).

    CAS  Article  Google Scholar 

  8. Thanh, L.T., Man, N., Helliwell, T.R. & Morris, G.E. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Am. J. Hum. Genet. 56, 725–731 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Sherratt, T.G., Vulliamy, T. & Strong, P.N. Evolutionary conservation of the dystrophin central rod domain. Biochem J 287, 755– 759 (1992).

    CAS  Article  Google Scholar 

  10. Hoffman, E.P., Morgan, J.E., Watkins, S.C. & Partridge, T. A Somatic reversion/suppression of the mouse mdx phenotype in vivo. J. Neurol. Sci. 99, 9– 25 (1990).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the support of the Muscular Dystrophy Group of Great Britain, The Leopold Muller Foundation, The Medical Research Council and the Parent Project for Duchenne Muscular Dystrophy Research.

Author information

Affiliations

  1. Muscle Cell Biology Group MRC Clinical Sciences Centre Imperial College School of Medicine, London, UK

    Terry Partridge & Qi Long Lu

  2. North East Wales Institute MRIC Biochemistry Group , Wrexham, UK

    Glenn Morris

  3. Department of Molecular Genetics and Biochemistry University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Eric Hoffman

Authors
  1. Terry Partridge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qi Long Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Glenn Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric Hoffman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Partridge, T., Lu, Q., Morris, G. et al. Is myoblast transplantation effective?. Nat Med 4, 1208–1209 (1998). https://doi.org/10.1038/3167

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/3167

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing